vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in vTv Therapeutics Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +9 vs. Q4 2025
- Shares held
- 1.49M
- +287.1K (+23.9%) vs. Q4 2025
- Total value
- $59.0M
- +$11.0M (+22.9%) vs. Q4 2025
- New holders
- 12
- 7 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 298,496 | $11.8M | 1.15% | 00.0% | Unchanged |
| FMR LLC | 260,391 | $10.3M | 0.00% | −8,465−3.1% | Reduced |
| Millennium Management LLC | 206,288 | $8.18M | 0.01% | +206,288 | New |
| Siren, L.L.C. | 163,000 | $6.46M | 0.18% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 148,314 | $5.88M | 0.03% | 00.0% | Unchanged |
| Trails Edge Capital Partners, LP | 139,578 | $5.54M | 1.30% | −91,422−39.6% | Reduced |
| Vanguard Capital Management LLC | 108,922 | $4.32M | 0.00% | +108,922 | New |
| Geode Capital Management, LLC | 32,886 | $1.31M | 0.00% | +4,692+16.6% | Added |
| Northern Trust Corp | 18,052 | $715.9K | 0.00% | +2,000+12.5% | Added |
| Vanguard Fiduciary Trust Co | 16,126 | $639.6K | 0.00% | +16,126 | New |
| 683 Capital Management, LLC | 16,000 | $634.6K | 0.06% | −2,268−12.4% | Reduced |
| Marshall Wace, LLP | 13,389 | $531.0K | 0.00% | +13,389 | New |
| Goldman Sachs Group Inc | 13,350 | $529.5K | 0.00% | +7,819+141.4% | Added |
| BlackRock, Inc. | 12,602 | $499.8K | 0.00% | +1,996+18.8% | Added |
| State Street Corp | 10,666 | $423.0K | 0.00% | +10,666 | New |
| Brevan Howard Capital Management LP | 7,531 | $298.7K | 0.00% | +7,531 | New |
| Pathstone Holdings, LLC | 6,073 | $240.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,636 | $223.5K | 0.00% | +3,968+237.9% | Added |
| Qube Research & Technologies Ltd | 5,618 | $222.8K | 0.00% | +5,618 | New |
| Vanguard Global Advisers, LLC | 1,275 | $50.6K | 0.00% | +1,275 | New |
| Morgan Stanley | 1,155 | $45.8K | 0.00% | +178+18.2% | Added |
| Advisor Group Holdings, Inc. | 1,119 | $44.4K | 0.00% | −1−0.1% | Reduced |
| Farther Finance Advisors, LLC | 283 | $11.5K | 0.00% | +4+1.4% | Added |
| Strengthening Families & Communities, LLC | 173 | $6.86K | 0.00% | +173 | New |
| Bessemer Group Inc | 112 | $4.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 43 | $2.00K | 0.00% | +43 | New |
| Activest Wealth Management | 50 | $1.98K | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 45 | $1.78K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 38 | $1.51K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 36 | $1.43K | 0.00% | +36 | New |
| Sunbelt Securities, Inc. | 15 | $595 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 9 | $357 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $79 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 2 | $79 | 0.00% | +2 | New |
| Strategic Wealth Partners, Ltd. | 1 | $40 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,268−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |